Novartis AG (NYSE:NVS)

96.76
Delayed Data
As of 4:10pm ET
 +0.47 / +0.49%
Today’s Change
74.97
Today|||52-Week Range
99.84
+2.19%
Year-to-Date
A Plan to Use Blockchain to Stop Counterfeit Drugs Moves Forward
1:55pm / MotleyFool.com - Paid Partner Content
How Incyte Beat Wall Street Estimates in Q4
Feb 13 / MotleyFool.com - Paid Partner Content
Merck's Chief Digital Officer Leaves to Join Marriott
Feb 20 / MotleyFool.com - Paid Partner Content
Incyte's Fourth-Quarter Report Signals Better Times Ahead
Feb 13 / MotleyFool.com - Paid Partner Content
FDA Approved 1,014 Generic Drugs in 2019
Feb 19 / MotleyFool.com - Paid Partner Content
Potential Lung Cancer Drug from Incyte and Novartis to Get a Priority Review from FDA
Feb 11 / MotleyFool.com - Paid Partner Content
Better Buy: Vertex Pharmaceuticals vs. Incyte
Feb 19 / MotleyFool.com - Paid Partner Content
Will Biogenís Big Patent Victory Ease Investor Worries About Its Alzheimerís Drug?
Feb 11 / MotleyFool.com - Paid Partner Content
Could This Cancer Drug Developerís Stock Make You Rich?
Feb 14 / MotleyFool.com - Paid Partner Content
Is Amgen a Stock to Buy?
Feb 08 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close96.29
Today’s open96.19
Day’s range95.97 - 96.96
Volume1,452,598
Average volume (3 months)1,685,857
Market cap$221.2B
Data as of 4:10pm ET, 02/21/2020

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+7.15%
Earnings growth (next 5 years)+9.70%
Revenue growth (last year)--
P/E ratio31.4
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MRKMerck-0.15-0.18%
PFEPfizer-0.13-0.36%
BMYBristol-Myers Squibb+0.46+0.71%
ABBVAbbVie+0.73+0.77%
Data as of 4:10pm ET, 02/21/2020

Financials

Next reporting dateApril 28, 2020
EPS forecast (this quarter)$1.37
Annual revenue (last year)$47.5B
Annual profit (last year)$11.6B
Net profit margin24.66%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts